🇺🇸 FDA
Pipeline program

Ondansetron (ODFS)

OND/CR/021/08-09/01906

Phase 1 small_molecule completed

Quick answer

Ondansetron (ODFS) for Healthy is a Phase 1 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aquestive Therapeutics
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials